Literature DB >> 16767416

Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation.

Undine E Lang1, Malek Bajbouj, Juergen Gallinat, Rainer Hellweg.   

Abstract

BACKGROUND: Vagus nerve stimulation (VNS) and repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex are brain stimulation techniques used as therapeutic interventions in major depression.
METHODS: In this study, we report the impact of these stimulation techniques on serum concentrations of brain-derived neurotrophic factor (BDNF) in treatment-resistant patients with a diagnosis of major depression.
RESULTS: We found no changes of BDNF serum concentrations and no association of neurotrophin concentrations in serum with clinical parameters in our sample.
CONCLUSION: Our preliminary results suggest that brain stimulation techniques-in contrast to several antidepressant medications-do not change BDNF serum concentrations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16767416     DOI: 10.1007/s00213-006-0399-y

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  Possible involvement of the BDNF-dependent pathway in treatment-emergent suicidality or decreased response to antidepressants.

Authors:  Shih-Jen Tsai
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

2.  Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity.

Authors:  Félicien Karege; Guido Bondolfi; Nicola Gervasoni; Michèle Schwald; Jean-Michel Aubry; Gilles Bertschy
Journal:  Biol Psychiatry       Date:  2005-05-01       Impact factor: 13.382

3.  Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.

Authors:  Ali Saffet Gonul; Fisun Akdeniz; Fatma Taneli; Ozlem Donat; Cagdas Eker; Simavi Vahip
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-06       Impact factor: 5.270

4.  Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy.

Authors:  Keisuke Kobayashi; Eiji Shimizu; Kenji Hashimoto; Makoto Mitsumori; Kaori Koike; Naoe Okamura; Hiroki Koizumi; Shintaro Ohgake; Daisuke Matsuzawa; Lin Zhang; Michiko Nakazato; Masaomi Iyo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-06       Impact factor: 5.067

Review 5.  Brain-derived neurotrophic factor and antidepressant activity.

Authors:  A A Russo-Neustadt; M J Chen
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

6.  Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.

Authors:  Eiji Shimizu; Kenji Hashimoto; Naoe Okamura; Kaori Koike; Naoya Komatsu; Chikara Kumakiri; Michiko Nakazato; Hiroyuki Watanabe; Naoyuki Shinoda; Sin-ichi Okada; Masaomi Iyo
Journal:  Biol Psychiatry       Date:  2003-07-01       Impact factor: 13.382

7.  Neuroprotection and neuronal dysfunction upon repetitive inhibition of oxidative phosphorylation.

Authors:  R Hellweg; C A F von Arnim; M Büchner; R Huber; M W Riepe
Journal:  Exp Neurol       Date:  2003-10       Impact factor: 5.330

8.  Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets.

Authors:  Félicien Karege; Michèle Schwald; Mbaye Cisse
Journal:  Neurosci Lett       Date:  2002-08-16       Impact factor: 3.046

Review 9.  Critical role of brain-derived neurotrophic factor in mood disorders.

Authors:  Kenji Hashimoto; Eiji Shimizu; Masaomi Iyo
Journal:  Brain Res Brain Res Rev       Date:  2004-05

Review 10.  Role of neurotrophic factors in the etiology and treatment of mood disorders.

Authors:  Ronald S Duman
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

View more
  24 in total

Review 1.  Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review.

Authors:  Giovanni Assenza; Mario Tombini; Jacopo Lanzone; Lorenzo Ricci; Vincenzo Di Lazzaro; Sara Casciato; Alessandra Morano; Anna Teresa Giallonardo; Carlo Di Bonaventura; Ettore Beghi; Edoardo Ferlazzo; Sara Gasparini; Loretta Giuliano; Francesco Pisani; Paolo Benna; Francesca Bisulli; Fabrizio A De Falco; Silvana Franceschetti; Angela La Neve; Stefano Meletti; Barbara Mostacci; Ferdinando Sartucci; Pasquale Striano; Flavio Villani; Umberto Aguglia; Giuliano Avanzini; Vincenzo Belcastro; Amedeo Bianchi; Vittoria Cianci; Angelo Labate; Adriana Magaudda; Roberto Michelucci; Annapia Verri; Gaetano Zaccara; Vincenzo Pizza; Paolo Tinuper; Giancarlo Di Gennaro
Journal:  Neurol Sci       Date:  2020-06-10       Impact factor: 3.307

2.  Serum BDNF levels before treatment predict SSRI response in depression.

Authors:  Owen M Wolkowitz; Jessica Wolf; Wendy Shelly; Rebecca Rosser; Heather M Burke; George K Lerner; Victor I Reus; J Craig Nelson; Elissa S Epel; Synthia H Mellon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-07-03       Impact factor: 5.067

Review 3.  Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484).

Authors:  M L Molendijk; P Spinhoven; M Polak; B A A Bus; B W J H Penninx; B M Elzinga
Journal:  Mol Psychiatry       Date:  2013-08-20       Impact factor: 15.992

4.  Serial repetitive transcranial magnetic stimulation (rTMS) decreases BDNF serum levels in healthy male volunteers.

Authors:  Gerd Schaller; Wolfgang Sperling; Tanja Richter-Schmidinger; Christiane Mühle; Annemarie Heberlein; Christian Maihöfner; Johannes Kornhuber; Bernd Lenz
Journal:  J Neural Transm (Vienna)       Date:  2013-10-25       Impact factor: 3.575

Review 5.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

6.  Carbonic anhydrase I, II, and VI, blood plasma, erythrocyte and saliva zinc and copper increase after repetitive transcranial magnetic stimulation.

Authors:  Robert I Henkin; Samuel J Potolicchio; Lucien M Levy; Ramy Moharram; Irina Velicu; Brian M Martin
Journal:  Am J Med Sci       Date:  2010-03       Impact factor: 2.378

7.  Association study of theta EEG asymmetry and brain-derived neurotrophic factor gene variants in childhood-onset mood disorder.

Authors:  Natalie L Bulgin; John S Strauss; Nicole A King; Sajid A Shaikh; Charles J George; Nathan A Fox; Cathy L Barr; Maria Kovacs; James L Kennedy
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843

8.  Neuron specific enolase and serum remain unaffected by ultra high frequency left prefrontal transcranial magnetic stimulation in patients with depression: a preliminary study.

Authors:  Heiko Ullrich; Laura Kranaster; Erich Sigges; Jürgen Andrich; Alexander Sartorius
Journal:  J Neural Transm (Vienna)       Date:  2013-06-05       Impact factor: 3.575

Review 9.  Measurement methods of BDNF levels in major depression: a qualitative systematic review of clinical trials.

Authors:  Stefania Pigatto Teche; Gabriela Lotin Nuernberg; Anne Orgler Sordi; Lívia Hartmann de Souza; Lysa Remy; Keila Maria Mendes Ceresér; Neusa Sica Rocha
Journal:  Psychiatr Q       Date:  2013-12

10.  Brain-derived neurotrophic factor: role in depression and suicide.

Authors:  Yogesh Dwivedi
Journal:  Neuropsychiatr Dis Treat       Date:  2009-08-20       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.